What is BTTC

The Brain Tumor Trials Collaborative (BTTC) was created in 2004 as a network of medical centers with the expertise and the desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors.

Learn more about BTTC

Our Mission

The mission of the BTTC is to develop and perform hypothesis-based, state-of-the-art clinical trials in a collaborative and collegial environment emphasizing innovation and meticulous attention to protocol compliance and data quality. Through these efforts, the BTTC will strive to advance treatments for patients with neuro-oncologic illness with recognition of the importance of merging good scientific method with concern for patient well-being and outcome.

Learn more about our Mission and Goals

Participating Doctors

Each doctor in the BTTC network understands the emotions and challenges of living with a malignant brain tumor. It's part of what drives each physician's dedication to finding a cure.

See a list of participating doctors

Participating Institutions

It is the goal of the M.D. Anderson Cancer Center and all BTTC participating institutions to eliminate cancer through outstanding programs that integrate patient care, research and prevention.

Learn more about participating institutions

Sponsors – Head for the Cure


Head for the Cure event pic

Each year about 200,000 people in the U.S. are diagnosed with a primary or metastatic brain tumor. Improving the outlook for adults and children requires research of the causes and better treatment.

Head for the Cure events and activities generated $225,000 in 2009 to support the Chris Anthony Brain Tumor Research Fund. This, in turn, provides funding for the Brain Tumor Trials Collaborative (BTTC).

Learn about the Head for the Cure successes

Register

If you cannot participate in Head for the Cure, you can still make a difference with your donation.

Donate Now

Print Close | X

Term
View full glossary directory